Henan Xinxiang Huaxing Biopharmaceutical

Henan Xinxiang Huaxing Biopharmaceutical is a Chinese pharmaceutical manufacturing entity established in 2010 in Xinxiang, Henan. Available registry information indicates that the company is active but its registered business scope is limited to preparatory construction of a pharmaceutical project rather than ongoing commercial operations. Publicly described project plans referenced recombinant human serum albumin made using genetic engineering, alongside API and formulation capacity for cephalosporins, macrolides, and vitamins. The company appears affiliated with and majority-owned by Henan Xinxiang Huaxing Pharmaceutical Factory, a larger local pharmaceutical manufacturer. Based on the available evidence, it should be viewed as a project-stage biopharmaceutical subsidiary rather than a fully developed biotech with a disclosed clinical pipeline.